Im not sure if you watched stamlers presentation post the 202 study results, but he did say they will approach MJFF after the 201 results (possibly before) and had stated they are getting quite a bit of interest, so there is no doubt alot of discussions, and interest is occurring behind closed doors, so funding for phase 3 may be covered through the "sophisticated investors".
If they can patent the MRI AI tool than that will give secondary funding for Alterity.
It was interesting to note that they sponsored the latest presentation in Santa Barbara. So I definately agree they are quietly and precisely getting noticed. And every presentation is as impressive as the last.
I did a google enquiry about ATH share price predicition, and one site advised that ATH should see an improvement from December, and they are less likely to be exposed to shorters as they keep the information quite (as in very rare a price sensitive alert is given, or has been given with all previous presentations), so they are targeting the audience they want.
As we all know, the 201 study is going to be/should be the start of a run north.
So close.
ATH Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)